Imatinib Mesylate in Advanced Dermatofibrosarcoma Protuberans: Pooled Analysis of Two Phase II Clinical TrialsPiotr Rutkowski, Scott M. Schuetze, Maria Dêbiec‐Rychter et al.|Journal of Clinical Oncology|2010Cited by 401